The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study
Sriwijaya Journal of Internal Medicine · 2023
DOI: 10.59345/sjim.v1i2.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sriwijaya Journal of Internal Medicine, 2023. Verfasst von Isabella Alvarez und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Gastric inhibitory polypeptide (GIP) is an incretin hormone with a complex role in glucose homeostasis. While it stimulates insulin secretion, it has also been implicated in adiposity and potentially in the pathogenesis of type 2 diabetes mellitus (T2DM). This longitudinal study investigated the relationship between GIP levels and the development of T2DM in a Spanish cohort.
Methods
We followed 1,200 non-diabetic Spanish adults (aged 40-65 years) for 10 years. Baseline measurements included anthropometric data, fasting GIP levels, oral glucose tolerance tests (OGTT), and lifestyle factors. Incident T2DM cases were identified through OGTT and medical records. Cox proportional hazard models were used to assess the association between GIP and T2DM risk, adjusting for potential confounders.
Results
During the follow-up, 187 participants developed T2DM. Baseline GIP levels were significantly higher in individuals who developed T2DM compared to those who remained non-diabetic (p
Zitieren
APA
Alvarez, I., & Perez, D. (2023). The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study. Sriwijaya Journal of Internal Medicine. https://doi.org/10.59345/sjim.v1i2.76
Vancouver
Alvarez I, Perez D. The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study. Sriwijaya Journal of Internal Medicine. 2023. doi:10.59345/sjim.v1i2.76
BibTeX
@article{Alvarez2023,
author = {Alvarez, Isabella and Perez, Daniel},
title = {The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study},
journal = {Sriwijaya Journal of Internal Medicine},
year = {2023},
doi = {10.59345/sjim.v1i2.76}
}
EUVIMED